Marc E. Rothenberg
Cincinnati Children's Hospital Medical Center 3333 Burnet Ave, Cincinnati Ohio 45229, United States · Children's Hospital Medical Center, Cincinnati · Cincinnati Children's Hospital Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
16
all conditions, ClinicalTrials.gov
NIH grants tied to them
18
1 more share only the name and are not shown
Trial papers
43
PubMed author-name match
Trials
Studies that name Marc E. Rothenberg as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:31 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05251909 · Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)AstraZeneca · terminated · Eosinophilic Gastritis, Eosinophilic Gastroenteritis · principal investigator
- Ph3NCT04543409 · A Study of Benralizumab in Patients With Eosinophilic EsophagitisAstraZeneca · terminated · Eosinophilic Esophagitis · principal investigator
- Ph2/Ph3NCT03473977 · Benralizumab for Eosinophilic Gastritis (BEGS)Children's Hospital Medical Center, Cincinnati · completed · Eosinophilic Gastritis or Gastroenteritis
- Ph2NCT03029091 · An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)Children's Hospital Medical Center, Cincinnati · completed · Eosinophilic Esophagitis
- N/ANCT02897271 · Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site CohortChildren's Hospital Medical Center, Cincinnati · completed · Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Gastroenteritis
- Ph2/Ph3NCT02778867 · SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet StudyChildren's Hospital Medical Center, Cincinnati · completed · Eosinophilic Gastrointestinal Disorders (EGIDs), Eosinophilic Esophagitis (EoE)
- Ph2/Ph3NCT02610816 · Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed GlucocorticoidsChildren's Hospital Medical Center, Cincinnati · completed · Eosinophilic Esophagitis, Eosinophilic Gastrointestinal Disorders (EGIDs)
- N/ANCT02523118 · OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the AgesChildren's Hospital Medical Center, Cincinnati · recruiting · Eosinophilic Gastrointestinal Disorders (EGIDs), Eosinophilic Esophagitis, Eosinophilic Gastritis
- Ph2NCT01808196 · Testing Effectiveness of Losartan in Patients With EoE With or Without a CTDChildren's Hospital Medical Center, Cincinnati · completed · Eosinophilic Esophagitis, Connective Tissue Disorders
- N/ANCT01382563 · Registry for Eosinophilic Gastrointestinal Disorders (REGID)Children's Hospital Medical Center, Cincinnati · completed · Eosinophilic Gastrointestinal Disorders (EGID), Eosinophilic Esophagitis, Eosinophilic Disorder · principal investigator
- N/ANCT01323803 · Eosinophilic Esophagitis DatabankNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Esophagitis, Eosinophilic Esophagitis · principal investigator
- Ph2NCT00426283 · A Study of Flovent in Patients With Eosinophilic EsophagitisMarc Rothenberg, MD · completed · Eosinophilic Esophagitis · principal investigator
- N/ANCT00267501 · Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic DisordersChildren's Hospital Medical Center, Cincinnati · recruiting · Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease, Food Allergy · principal investigator
- N/ANCT00267475 · Data Bank for Eosinophilic DisordersMarc Rothenberg · completed · Eosinophilic Esophagitis, Gastritis, Enteritis · principal investigator
- Ph1/Ph2NCT00266565 · Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic SyndromeChildren's Hospital Medical Center, Cincinnati · completed · Hypereosinophilic Syndromes, Eosinophilic Gastroenteritis, Churg-Strauss Syndrome · principal investigator
- Ph3NCT00266578 · A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic DisordersMarc Rothenberg · completed · Eosinophilic Esophagitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical Trial 2: UPGRADEU54AI117804 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2014 to 2026 · $612,444 awarded in 2026Grant number is on one of their registry trials
- Consortium of Food Allergy Research Clinical Research Center at Cincinnati Children's Hospital Medical Center (CoFAR-CRC:CCHMC)U01AI181966 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2024 to 2026 · $380,000 awarded in 2026Same name and institution; not confirmed by an ID
- Genetic and Immunological Dissection of Eosinophilic EsophagitisR01AI124355 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2015 to 2026 · $678,808 awarded in 2026Same name and institution; not confirmed by an ID
- Role of NOD2 Variants in Eosinophilic EsophagitisU19AI070235 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2006 to 2026 · $374,455 awarded in 2026Same name and institution; not confirmed by an ID
- Regulation of Gastrointestinal EosinophilsR01AI045898 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 1999 to 2024 · $453,145 awarded in 2024Same name and institution; not confirmed by an ID
- Roles of FFAR 3-SCFA axis in Th2 cytokine production by tissuelymphocytes in EoER01AI148138 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2021 to 2024 · $397,500 awarded in 2024Same name and institution; not confirmed by an ID
- Role of Aiolos in eosinophilic asthmaR01AI130033 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2019 to 2021 · $390,000 awarded in 2021Same name and institution; not confirmed by an ID
- Regulation of Gastrointestinal EosinophilsR37AI045898 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2010 to 2019 · $390,000 awarded in 2019Same name and institution; not confirmed by an ID
- Immunology/Allergy Fellowship Training GrantT32AI060515 · NIAID · UNIVERSITY OF CINCINNATI · fiscal years 2014 to 2018 · $297,200 awarded in 2018Same name and institution; not confirmed by an ID
- IL-13 Associated Eosinophil Lung ResponsesR01AI083450 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2009 to 2013 · $352,396 awarded in 2013Same name and institution; not confirmed by an ID
- IL-13 and Eosinophilic EsophagitisR01DK076893 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2007 to 2011 · $295,353 awarded in 2011Same name and institution; not confirmed by an ID
- A multi-center clinical trial of 1760 mcg of daily swallowed fluticasone vs. placU01AI088806 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2009 to 2010 · $137,250 awarded in 2010Same name and institution; not confirmed by an ID
- CLINICAL TRIAL: EFFECT OF INTRAVENOUS ANTI-IL5 (MEPOLIZUMAB) IN HYPEREOSINOPHILIM01RR008084 · NCRR · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2004 to 2008 · $3,641 awarded in 2008Same name and institution; not confirmed by an ID
- CORE--Breeding and GenotypingP01HL076383 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2004 to 2008 · $86,565 awarded in 2008Same name and institution; not confirmed by an ID
- Eosinophil, Chemokine and IL-13 Cooperativity in AsthmaR01AI057803 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2004 to 2007 · $176,599 awarded in 2007Same name and institution; not confirmed by an ID
- Role of arginase in allergic airway inflammationR01AI053479 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2003 to 2007 · $353,197 awarded in 2007Same name and institution; not confirmed by an ID
- Anti-IL 5 for HypereosinophiliaR01FD002396 · FDA · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2005 · $234,119 awarded in 2005Same name and institution; not confirmed by an ID
- MECHANISMS OF EOSINOPHILIA IN EXPERIMENTAL ASTHMAR01AI042242 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 1998 to 2002 · $250,123 awarded in 2002Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- U54AI117870RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT02523118
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:31 UTC. The ranking covers the 200 most relevant of 43 PubMed records, and a shared surname and initials can bring in a namesake. All 43 on PubMed
- Treatment of patients with the hypereosinophilic syndrome with mepolizumab.N Engl J Med · 2008468 citationsRCR 11.3
- A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.Gastroenterology · 2006460 citationsRCR 12.6
- Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.J Allergy Clin Immunol · 2012451 citationsRCR 14.2
- Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.N Engl J Med · 2022415 citationsRCR 38.4
- Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.Gastroenterology · 2020373 citationsRCR 22.1
- Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.J Allergy Clin Immunol · 2006341 citationsRCR 8.3
- Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.J Allergy Clin Immunol · 2004299 citationsRCR 7.4
- Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.J Allergy Clin Immunol · 2015249 citationsRCR 8.8
- Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.N Engl J Med · 2020235 citationsRCR 12.1
- RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.Gastroenterology · 2019224 citationsRCR 10.6